Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 18Neoplasms, Hormone-Dependent 2Carcinoma, Lobular 2Carcinoma, Ductal, Breast 2Polycystic Ovary Syndrome 1Hot Flashes 1Breast Cancer Metastatic 1Advanced Breast Cancer 1

Interventions

fluzoparib 1exemestane 1dalpiciclib 1Trastuzumab 1Letrozole 1Ga(III)-DOTATOC 1Everolimus 1Docetaxel 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Cancer Metastatic × Aromatase Inhibitors × Clear all
NCT02511639 2020-12-03

MAIN-A

Istituto Oncologico Veneto IRCCS

Phase 3 Completed
110 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡